Navamedic ASA: Enters into partnership agreement for distribution of ELMIRON® in the Nordics
Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH (bene) for the Nordic launch and commercialisation of ELMIRON®, the only EU approved oral medication used to treat adults with bladder pain syndrome. "We are very pleased to announce the partnership with bene-Arzneimittel for distribution of the prescription medicine, ELMIRON (pentosan polysulfate sodium), in the Nordics. ELMIRON is used to treat adults with moderate to severe pain related to